Cash burn and runway

Hong Kong IPO disclosure precedents · 136 companies, 136 items

cash burn rate and how many months existing cash will last (typically Chapter 18A / 18C, loss-making issuers)

2026-06-18Application Proof
Guangzhou Zhiyi Biotechnology Co., Ltd.广州知易生物科技股份有限公司

Assuming an average cash burn rate going forward of 4.2 times the level in 2025, taking into account the scheduled payment of indebtedness, we estimate that our cash at bank and on hand, together with other investments as of April 30, 2026 will be able to maintain our financial viability for 9 months, or, if we also take into account the estimated net [REDACTED] (based on the [REDACTED] of HK$[REDACTED] per Share), 54 months.

Financial Information · p. 258

Taking into account the estimated net [REDACTED] from the [REDACTED] and the financial resources available to us, including cash and cash equivalents, and considering our cash burn rate, our Directors are of the view that we have sufficient working capital to cover at least 125% of our costs, including research and development expenses and general and administrative expenses and for at least the next 12 months from the date of this Document.

Financial Information · p. 258
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-06-18Application Proof
CSPC Innovation Pharmaceutical Co., Ltd.石药创新制药股份有限公司

Our cash burn rate refers to the average monthly aggregate amount of net cash used in operating activities and payments for capital expenditures.

Business · p. 186

(i) cash and cash equivalents and financial assets at FVTPL as of April 30, 2026 will be able to maintain our financial viability for [17] months, (ii) if we take into account the AZ Upfront Payment, [57] months, (iii) if we take into account 10.0% of the estimated [REDACTED] from the [REDACTED] and the AZ Upfront Payment, [61] months, or (iv) if we take into account all estimated [REDACTED] from the [REDACTED] and the AZ Upfront Payment, [94] months.

Business · p. 187

Taking into account the financial resources available to us, and the estimated [REDACTED] from the [REDACTED], our Directors are of the view that we have available sufficient working capital for our present requirements that is for at least the next 12 months from the date of this document.

Business · p. 186
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-06-18Prospectus
Alebund Pharmaceuticals (Jiangsu) Limited礼邦医药(江苏)股份有限公司09637.HK

Excluding one-off capital expenditures spent on building our manufacturing facilities and assuming an average cash burn rate going forward of 1.4 times the level as of December 31, 2025, we estimate that our cash at bank and on hand and other financial assets as of December 31, 2025 will be able to maintain our financial viability for 47 months from December 31, 2025 taking into account the estimated net proceeds from the Global Offering, net of capitalized listing expenses; or we estimate that we will be able to maintain our financial viability for 15 months from December 31, 2025 without taking into account the estimated net proceeds from the Global Offering, net of capitalized listing expenses.

Summary · p. 11
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-06-18Prospectus
Baige Online Digital Technology Co., Ltd.白鸽在线(厦门)数字科技股份有限公司02672.HK

Our historical cash burn rate was nil, RMB0.9 million and nil in 2023, 2024 and 2025, respectively.

Financial Information · p. 307

We did not record material cash burn in 2025, and we expect our operating cash inflow will be at a surplus position based on the underlying assumptions that (i) our workforce growth will generally align with our business expansion, (ii) we expect to increase investment in research and development in phases, (iii) we do not expect substantial capital investment unless earmarked fund-in, and (iv) we do not expect significant acquisitions of fixed assets.

Financial Information · p. 307

We will continue to monitor our cash flow from operations closely and maintain our financial viability through a variety of means, including, among others, banking facilities and external financing.

Financial Information · p. 307
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-06-16Application Proof
Shanghai Juncell Therapeutics Co., Ltd.上海君赛生物股份有限公司

Our cash burn rate refers to the average monthly amount of net cash used in operating activities, capital expenditures and lease payments.

Financial Information · p. 247

Our Directors are of the opinion that, taking into account the financial resources available, including cash and bank balances, the expected income from commercialization of GC101 in China, and the estimated net [REDACTED] from the [REDACTED], as well as our cash burn rate, we have sufficient working capital to cover at least 125% of our costs, including research and development expenses and administrative expenses for at least the next 12 months from the date of this Document.

Financial Information · p. 247
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-06-15Prospectus
Shaanxi Micot Pharmaceutical Technology Co., Ltd.陕西麦科奥特医药科技股份有限公司02335.HK

Assuming an average cash burn rate going forward of 1.5 times of the level for 2025, we estimate that our cash and cash equivalents and term deposits of RMB202.5 million as of April 30, 2026 will be able to maintain our financial viability for approximately 10 months or, if we take into account 10% of the estimated net proceeds from the Global Offering (namely, the portion used for working capital and general corporate purposes), approximately 15 months or, if we also take into account the estimated net proceeds from the Global Offering, approximately 54 months.

Financial Information · p. 266

Our Directors are of the view that, taking into account the financial resources available to us, including cash and cash equivalents, and the estimated net proceeds from the Global Offering, we have sufficient working capital to cover at least 125% of our costs, including R&D expenses, administrative expenses, other operating expenses and necessary capital expenditure, for at least the next 12 months from the date of this prospectus.

Financial Information · p. 266
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-06-15Application Proof
Lynk Pharmaceuticals Co., Ltd.凌科药业(浙江)股份有限公司

Taking into account our cash and cash equivalents and financial products we purchased, and assuming average monthly net cash used in operating activities and capital expenditures going forward of 1.5 times the average level in the year ended December 31, 2025, we estimate we will be able to maintain our financial viability for 12 months without considering [REDACTED] from the [REDACTED]; or, if we also take into account the net [REDACTED] from [REDACTED], assuming an [REDACTED] of HK$[REDACTED] per [REDACTED] (being the low-end of the indicative [REDACTED]), [REDACTED] months.

Financial Information · p. 230

We will continue to monitor our cash flows from operations closely and expect to raise our next round of financing, if needed, with a minimum buffer of 12 months.

Financial Information · p. 230
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-06-15Prospectus
Shanghai Seer Intelligent Technology Co., Ltd.上海仙工智能科技股份有限公司06106.HK

Our historical cash burn rate was RMB25 thousand, RMB2.7 million and RMB3.3 million in 2023, 2024 and 2025, respectively.

Financial Information · p. 248

we estimate that our cash and cash equivalents, financial assets at fair value through profit or loss and unutilized banking facilities as of December 31, 2025 will be able to maintain our financial viability for approximately 105.6 months or, if we take into account 5.3% of the estimated net proceeds from the Global Offering (namely the portion allocated for our working capital and other general corporate purposes), approximately 119.6 months or, if we take into account the estimated net proceeds from the Global Offering, approximately 369.0 months.

Financial Information · p. 248
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-06-12Prospectus
HJ Science Co., Ltd.华健未来(成都)科技股份有限公司06132.HK

Assuming an average cash burn rate going forward of 2.3 times the level in 2025, we estimate that our cash and cash equivalents and financial assets at FVTPL as of April 30, 2026 will be able to maintain our financial viability for 18 months or, if we take into account 10% of the estimated net proceeds from the Listing (namely, the portion allocated for our working capital and other general corporate purposes), 23 months or, if we also take into account the estimated net proceeds from the Listing, 69 months.

Financial Information · p. 277

We will continue to monitor our cash flows from operations closely and expect to raise our next round of financing, if needed, with a minimum buffer of 12 months.

Financial Information · p. 277
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-06-12Application Proof
Yantai Lannacheng Biotechnology Co., Ltd.烟台蓝纳成生物技术股份有限公司

Our cash burn rate refers to the average monthly amount of net cash used in operating activities and capital expenditures.

Financial Information · p. 275

Assuming an average cash burn rate going forward of 1.3 times the level during the year ended December 31, 2025, we estimate that our cash and cash equivalents as of April 30, 2026 will be able to maintain our financial viability for [7] months, or, if we take into account the estimated [REDACTED] from the [REDACTED], [36] months.

Financial Information · p. 275

We will continue to monitor our cash flows from operations closely and expect to raise our next round of financing no earlier than six months after the completion of the [REDACTED].

Financial Information · p. 275
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-06-12Application Proof
Trunk Technology (Beijing) Co., Ltd.主线科技(北京)股份有限公司

Our historical cash burn rate was RMB7.6 million, RMB7.8 million and RMB8.0 million in 2023, 2024 and 2025, respectively.

Financial Information · p. 245

We had cash and cash equivalents, financial assets at FVTPL, term deposits and unutilized bank facilities of RMB352.8 million as of April 30, 2026.

Financial Information · p. 245

we estimate that our cash and cash equivalents, financial assets at FVTPL, term deposits and unutilized bank facilities as of April 30, 2026 will be able to maintain our financial viability (i) for [22] months

Financial Information · p. 245
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-06-10Application Proof
PPLabs Technology Limited派想未来集团

Our historical cash burn rate was RMB5.5 million, RMB6.2 million and RMB13.9 million for each of the years ended December 31, 2023, 2024 and 2025.

Financial Information · p. 245

As of April 30, 2026, our cash balance was RMB350.9 million, including cash and cash equivalents RMB151.5 million, financial assets at fair value through profit or loss RMB114.5 million and unutilised banking facilities RMB84.9 million, as they represent available liquidity to fund our operations.

Financial Information · p. 245

We will continue to monitor our cash flows from operations closely and maintain our financial viability through a variety of means, including, among others, banking facilities and external financings.

Financial Information · p. 245
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-06-08Application Proof
GANZHOU HEMAY PHARMACEUTICAL CO., LTD.赣州和美药业股份有限公司

Assuming the average cash burn rate going forward is 1.5 times the cash burn rate in 2025, we estimate that our cash and cash equivalents and term deposit as of April 30, 2026 will be able to maintain our financial viability for approximately 10.4 months from April 30, 2026 , without taking into account the estimated [REDACTED] from the [REDACTED], or, we estimate we will be able to maintain our financial viability for approximately 77.0 months from April 30, 2026 , if we take into account the estimated [REDACTED] from the [REDACTED].

Financial Information · p. 257

Our Directors are of the opinion that, taking into account the following financial resources available to us, including the cash and cash equivalents on hand, anticipated cash inflow from unutilized bank facilities and the estimated [REDACTED] from the [REDACTED], we have sufficient working capital to cover at least 125% of our costs, including research and development expenses, general and administrative expenses, and selling and marketing expenses, for at least the next 12 months from the date of this document.

Financial Information · p. 257

We will continue to monitor our cash flows from operations closely and expect to raise our next round of financing at least six months after the completion of the [REDACTED].

Financial Information · p. 257
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-06-08Application Proof
Hangzhou Highlightll Pharmaceutical Co., Ltd.杭州高光制药股份有限公司

We had cash and cash equivalents, financial assets at FVPL and time deposits of RMB341.6 million as of April 30, 2026.

Financial Information · p. 243

Assuming an average cash burn rate going forward of 1.3 times of the level in the four months ended April 30, 2026 and without taking into account any cash inflows from milestone payments, we estimate that our cash and bank balances, financial assets at FVPL and time deposits as of April 30, 2026 will be able to maintain our financial viability for [REDACTED] months or, if we take into account the estimated [REDACTED] from the [REDACTED], [REDACTED] months.

Financial Information · p. 243

We will continue to monitor our cash flows from operations closely and expect to raise our next round of financing.

Financial Information · p. 243
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-05-31Application Proof
Chengdu CRP Robot Technology Co., Ltd.成都卡诺普机器人技术股份有限公司

Our historical cash burn rate was RMB2.9 million, RMB2.2 million and RMB3.5 million in 2023, 2024 and 2025, respectively. We had cash and cash equivalents, current financial assets at fair value through profit or loss of RMB176.1 million as of December 31, 2025 and unutilized banking facilities of RMB412.4 million as of December 31, 2025.

Summary · p. 13

Our historical cash burn rate was RMB2.9 million, RMB2.2 million and RMB3.5 million for the years ended December 31, 2023, 2024 and 2025, respectively.

Financial Information · p. 250

We will continue to monitor our cash flows from operations closely and maintain our financial viability through a variety of means, including, among others, banking facilities and external financings.

Summary · p. 13
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-05-29Application Proof
Genuine Biotech Limited真实生物科技有限公司

Assuming that our cash burn rate going forward will be two times the cash burn rate level during the Track Record Period and taking into account the available financing facilities and expected repayments, we estimate that we will have sufficient cash to maintain our financial viability for approximately 10 months from December 31, 2025, or, if we take into account the estimated [REDACTED] from the [REDACTED], at least 30 months from December 31, 2025.

Financial Information · p. 261

We will continue to monitor our cash flows from operations closely and expect to raise our next round of financing, if needed, with a minimum buffer of 12 months.

Financial Information · p. 261

Our Directors are of the opinion that, taking into account the financial resources available to our Group, including cash and cash equivalents, internally generated funds, available financing facilities and the estimated [REDACTED] from the [REDACTED], we have sufficient working capital to cover at least 125% of our costs, including research and development expenses, selling and distribution expenses and administrative expenses, for at least the next 12 months from the date of this document.

Financial Information · p. 261
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-05-28Application Proof
Lupeng Pharmaceutical Ltd.麓鹏制药有限公司

Assuming an average cash burn rate going forward of 3.1 times the level in 2025, we estimate that (i) our cash and cash equivalents will be able to maintain our financial viability for 21 months, (ii) if we take into account [REDACTED]% of the estimated [REDACTED] from the [REDACTED] (namely, the portion allocated for our working capital and other general corporate purposes), [REDACTED] months, or, (iii) if we take into account all estimated [REDACTED] from the [REDACTED], [REDACTED] months.

Summary · p. 10

Our Directors are of the opinion that, taking into account the financial resources available, including cash and cash equivalents as of December 31, 2025 and unutilized bank facilities as of December 31, 2025 and the estimated [REDACTED] from the [REDACTED], as well as our cash burn rate, we have sufficient working capital to cover at least 125% of our costs, including research and development expenses, administrative expenses, other operating expenses and necessary capital expenditure for at least the next 12 months from the date of this document.

Summary · p. 10
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-05-28Prospectus
LongBio Pharma (Suzhou) Co., Ltd.天辰生物医药(苏州)股份有限公司01779.HK

Taking into account of the above, along with the estimated net proceeds from this Global Offering, the Directors are of the opinion, and the Sole Sponsor concurs, that we have sufficient working capital to cover at least 125% of our costs, including research and development costs, administrative expenses, finance costs and other operating costs, for at least the next 12 months from the date of this prospectus.

Summary · p. 10

Assuming an average cash burn rate going forward of 1.3 times the level in the year ended December 31, 2025, we estimate that (i) our cash and cash equivalents, restricted cash and financial assets at FVTPL as of December 31, 2025 will be able to maintain our financial viability for over 13 months from December 31, 2025, (ii) if we take into account 10.0% of the estimated net proceeds from the Global Offering (namely, the portion allocated for our working capital and other general corporate purposes), 21 months, and (iii) if we take into account 100.0% of the estimated net proceeds from the Global Offering, 91 months.

Summary · p. 10

Our cash burn rate refers to average monthly amount of net cash used in operating activities, capital expenditures and lease payments.

Financial Information · p. 243
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-05-27Application Proof
Shanghai Simpletouch Robot Co., Ltd.上海睿触机器人股份有限公司

As of October 31, 2025, we had cash and cash equivalents of RMB71.3 million.

Financial Information · p. 321

Assuming that the average cash burn rate going forward will be 2.5 times the level in the year ended December 31, 2024, we estimate that our cash and cash equivalents as of October 31, 2025 will be able to maintain our financial viability for 11.5 months, or, if we also take into account the estimated net [REDACTED] (based on the low-end of the indicative [REDACTED]) from the [REDACTED], for at least 109.0 months.

Financial Information · p. 321

After taking into consideration the above, and the net [REDACTED] from the [REDACTED], in the absence of unforeseeable circumstances, our Directors are of the opinion that we have sufficient working capital to cover at least 125% of our costs, including R&D costs, selling and distribution expenses and administrative expenses for at least the next 12 months from the date of this document.

Financial Information · p. 321
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-05-26Prospectus
BEIJING SHOUGANG LANZATECH TECHNOLOGY CO., LTD.北京首钢朗泽科技股份有限公司02553.HK

Assuming that the average cash burn rate going forward will be similar to the cash burn rate level in 2025, we estimate that our cash and cash equivalents of RMB98.7 million and pledged deposits of RMB23.7 million (which will be gradually released before December 31, 2026), amounting to an aggregate of RMB122.4 million as of March 31, 2026, will be able to maintain our financial viability for approximately 11 months.

Business · p. 168

our Directors are of the view that we have sufficient working capital to meet our present and future requirements for at least the next 12 months from the date of publication of the Prospectus and until we achieve cash flow breakeven.

Business · p. 169
The company's explanation, the adviser's view and the page in the filing: see Matters

Tell us